ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

One-Pot Protein Synthesis

by Lauren K. Wolf
July 18, 2011 | APPEARED IN VOLUME 89, ISSUE 29

Chemists aiming to design drugs that target vascular endothelial growth factor (VEGF), a protein responsible for blood vessel growth in tumors, could now have a ready synthetic supply of it for their screening tests, thanks to a study (Angew. Chem. Int. Ed., DOI: 10.1002/anie.201103237). Researchers Kalyaneswar Mandal and Stephen B. H. Kent of the University of Chicago have devised a way of producing in one reaction vessel a 204-residue portion of the VEGF protein that is biologically active. “This is the largest protein molecule prepared by one-pot native chemical ligation,” the researchers write. To generate the truncated protein, which is a homodimer made of two 102-residue polypeptide chains joined by two disulfide bonds, Mandal and Kent started with three peptide segments and added them together sequentially. The segments covalently bind through the reaction of terminal cysteine groups and thioesters, eventually forming one of the 102-residue monomer chains. These chains then fold, forming three intrachain disulfide bonds each, and dimerize to yield the biologically active VEGF. What’s significant about the synthesis, Kent says, is the formation of a total of eight disulfide bonds at near-quantitative yield.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment